Metin Demirel

Mr. Metin Demirel

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2021 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
AGAyse Zehra Gul
Ayse Zehra Gul
NANil Atakul
Nil Atakul
SSSahabettin Selek
Sahabettin Selek
YAYıldız Atamer
Yıldız Atamer
USUfuk Sarıkaya
Ufuk Sarıkaya
MDMetin Demirel
Metin Demirel

20 June 2023 in Scandinavian Journal of Gastroenterology
Verified
Journal Article
Closed access
MDMetin Demirel
Metin Demirel
FKFatmanur Köktaşoğlu
Fatmanur Köktaşoğlu
EÖEsin Özkan
Esin Özkan
HAHalime Dulun Ağaç
Halime Dulun Ağaç
AGAyşe Zehra Gül
Ayşe Zehra Gül
ŞSŞahabettin Selek
Şahabettin Selek
Non-alcoholic fatty liver disease (NAFLD) is a disease characterized by the accumulation of excessive fat in the liver, which can lead to fibrosis and has an increasing prevalence. NAFLD requires non-invasive diagnostic biomarkers. While typically observed in overweight individuals, it can also occur in non-obese/non-overweight individuals. Comparative studies on non-obese NAFLD patients are scarce. This study aimed to conduct a using liquid chromatography-high resolution mass spectrometry (LC-MS/MS)-based metabolic profiling of non-obese NAFLD patients and healthy controls. The patient group consisted of 27 individuals with NAFLD, while the healthy control group included 39 individuals. Both groups were between 18 and 40 years old, had a BMI of less than 25 and had alcohol consumption less than 20 g/week for men and 10 g/week for women. Serum samples were collected and analyzed using LC-MS/MS. The data were analyzed using the TidyMass and MetaboAnalyst. The LC-MS/MS analyses detected significant changes in D-amino acid metabolism, vitamin B6 metabolism, apoptosis, mTOR signaling pathway, lysine degradation, and phenylalanine metabolism pathways in non-obese NAFLD patients. Significant changes were also observed in the metabolites D-pantothenic acid, hypoxanthine, citric acid, citramalic acid, L-phenylalanine, glutamine, and histamine-trifluoromethyl-toluidide, β-hydroxymyristic acid, DL-Lactic acid, and 3-methyl-2-oxopentanoic. Overall, the study provides valuable insights into the metabolic changes associated with non-obese NAFLD patients and can contribute to the development of non-invasive diagnostic biomarkers for NAFLD. This study sheds light on the metabolic changes in non-obese NAFLD patients. Further research is needed to better understand the metabolic changes associated with NAFLD and to develop effective treatment options.

30 June 2019 in Cellular and Molecular Biology
Verified
Journal Article
Closed access
PDF file
HCHifa Gulru Caglar
Hifa Gulru Caglar
SSSahabettin Selek
Sahabettin Selek
FKFatmanur Koktasoglu
Fatmanur Koktasoglu
IKIsmail Koyuncu
Ismail Koyuncu
MDMetin Demirel
Metin Demirel
SMSedat Meydan
Sedat Meydan
This study is aimed to investigate the effects of Camellia sinensis (CS), Hypericum perforatum (HP) and Urtica dioica (UD) in kidney and liver injury induced by carbon tetrachloride (CCl4) in rats. Highly toxic CCl4 which is used as a solvent in industry comprises experimental toxicity in rats and is widely used in hepatotoxicity and other tissue injury models. The purpose of this investigation is to monitor blood and various tissues by biochemical and histopathological analysis for preventive effects of CS, HP and UD on oxidative stress induced by administration of CCl4 and to enlighten the probable mechanism. Fifty eight rats were divided into five groups; sham group (Group 1, untreated animals), control CCl4 treated group (Group 2), HP extract-treated group (Group 3), UD extract-treated group (Group 4), CS extract-treated group (Group 5). All rats were anaesthetized at the end of the experiment and the blood was collected from each rat. Afterwards, tissue specimens were obtained. The tissue specimens were immersed in 10% formaldehyde for 24 hours. After routine tissue processing, the liver, kidney and stomach were sectioned in 5µm thickness, stained in hematoxylin and eosin. The histological study was performed by using light microscope. The serum marker enzymes were found to be significantly increased in CCl4–induced liver and kidney damage when compared with the sham group (p<0.05). However, treatment with CS, HP, and UD extracts resulted in decreased activity of serum enzymes. Malondialdehyde (MDA) levels were decreased by 20.51±0.95, 27.98±1.58, and 32.39±3.1 nmol/g wet weight protein in kidney homogenates and 16.65±1.75, 17.22±0.71 and 18.92±71 nmol/g wet weight protein in liver homogenates in CS, HP and UD treated groups, respectively. Our results have shown that additive antioxidants like CS, HP and UD will aid in diminishing these deviations in cases of liver and kidney dysfunction.

29 June 2023 in Journal of Chemical Metrology
Verified
Journal Article
Closed access
MDMetin Demirel
Metin Demirel
AGAyşe Zehra Gül
Ayşe Zehra Gül
FKFatmanur Köktaşoğlu
Fatmanur Köktaşoğlu
HAHalime Ağaç
Halime Ağaç
AGAhmet Ceyhan Goren
Ahmet Ceyhan Goren
ŞSŞahabettin Selek
Şahabettin Selek
Iron deficiency anemia is a prevalent type of anemia globally, caused mainly by the deficiency of iron, which is an essential component of various metabolic pathways. In this study, we aimed to investigate the changes in metabolite profiles resulting from alterations in these interconnected pathways. We selected 48 patients with IDA and 48 healthy participants based on diagnostic criteria for iron deficiency. NMR spectroscopy was utilized for metabolite profiling. Chenomx, MetaboAnalyst, and R were employed for data analysis. NMR analysis identified and quantified 119 metabolites. Significant metabolites between the two groups were determined using fold change (FC) analysis and t-test results. The FC values of the metabolite group ranked the following compounds in descending order: Acetoin, 2-Hydroxy-3-methylvalerate, Homogentisate, 3-Methylxanthine, Desaminotyrosine, Succinate, Methylguanidine, Guanidinosuccinate, 3-Methylglutarate, Ethanol, Carnosine, SN-Glycero-3-phosphocholine, and Homocysteine. The IDA patients had increased levels of Acetoin, 2-Hydroxy-3-methylvalerate, Homogentisate, 3-Methylxanthine, Succinate, Guanidinosuccinate, Ethanol, Carnosine, and SN-Glycero-3-phosphocholine, while decreased levels of Desaminotyrosine, Methylguanidine, and 3-Methylglutarate were observed. Our findings provide valuable insights into the different metabolites and pathways associated with IDA. Further molecular research is needed to validate these findings.

19 June 2025 in Reproductive Sciences
Verified
Journal Article
Open access
PDF file
MDMetin Demirel
Metin Demirel
MAMehtap Alim
Mehtap Alim
FKFatmanur Koktasoglu
Fatmanur Koktasoglu
NANil Atakul
Nil Atakul
EGEbru Guner
Ebru Guner
SSSahabettin Selek
Sahabettin Selek
Background: Infertility affects approximately 15% of reproductive-age couples, with polycystic ovary syndrome and poor ovarian reserve being major contributing factors. Metabolomic profiling of follicular fluid offers insights into the underlying metabolic disturbances associated with these infertility phenotypes. This study aims to identify metabolic biomarkers distinguishing PCOS, POR, and male factor infertility, which may facilitate improved diagnostic and therapeutic strategies. Methods: A total of 119 participants were categorized into three groups: PCOS (n = 39), POR (n = 40), and NOR (n = 40). Liquid chromatography–high-resolution mass spectrometry was used for untargeted metabolomic profiling. Metabolites were identified using HMDB, MassBank, and MoNA, while pathway analysis was performed using KEGG. Statistical analyses were conducted using R and Python, including one-way ANOVA, t-tests, and Mann-Whitney U tests, with False Discovery Rate correction applied. Results: Distinct metabolic alterations were observed among the groups. Trehalose-6-phosphate, taurocholate, and N,N-dimethylglycine emerged as the most significantly altered metabolites, showing strong discriminatory potential between PCOS and POR. PCOS patients exhibited reduced levels of taurocholate, mycalemide, and trehalose-6-phosphate, whereas NOR patients showed elevated levels of N,N-dimethylglycine and argininosuccinate. The POR group demonstrated increased levels of 1-methyl-2-pyrrolidone and haplopine, along with a broader metabolite distribution. Conclusion: This study reveals phenotype-specific metabolic signatures in PCOS and POR, identifying taurocholate, mycalemide, and N,N-dimethylglycine as potential follicular biomarkers. These findings contribute to a deeper understanding of the metabolic basis of infertility and highlight the potential of follicular fluid metabolomics for precision medicine in reproductive health.

12 November 2025 in Journal of Ovarian Research
Verified
Journal Article
Open access
PDF file
ÖÖÖmer Faruk Özer
Ömer Faruk Özer
AİAyşe Zeynep İbrahimoğlu
Ayşe Zeynep İbrahimoğlu
AGAyşe Zehra Gül
Ayşe Zehra Gül
MDMetin Demirel
Metin Demirel
SASeda Ateş
Seda Ateş
ŞSŞahabettin Selek
Şahabettin Selek
Polycystic ovary syndrome (PCOS) is a complex endocrine and metabolic disorder, and its diagnosis remains controversial due to heterogeneous phenotypes and varying diagnostic criteria. Insulin resistance and its metabolic consequences are central features of PCOS management. Metabolomics has increasingly been applied to elucidate the pathophysiology of complex disorders. In this study, we sought to determine which serum metabolites and metabolic pathways are differentially altered in women with PCOS compared with healthy controls, thereby addressing whether metabolomic profiling can reveal candidate biomarkers for early diagnosis and potential therapeutic targets. Fifty patients diagnosed with PCOS and 50 healthy controls matched for age and body mass index (BMI) were included in the study. Blood samples were collected for metabolomic analysis and routine biochemical parameters. Metabolomic analysis was performed by UPLC-HRMS and data were processed using MZmine, TidyMass and MetaboAnalyst. Metabolite annotation was performed using databases such as HMDB, MassBank and MoNA. Metabolomic analysis revealed 49 compounds in the serum of PCOS patients, 39 of which were upregulated and 10 of which were downregulated. Compounds such as di(2-ethylhexyl) phthalate (DEHP), promethazine N-oxide, tetrahydromagnolol, 5-methyl-5-phenylhydantoin, valerenic acid, butylparaben, erucamide, DDAO, d-erythro-sphinganin-1-phosphate and 1-arachidoyl-2-hydroxy-sn-glycero-3-phosphocholine were significantly higher in the PCOS group. Compounds such as L-methyladenosine, cystine, glu-gln and 2,2’-methylene-bis(6-tert-butyl-4-methylphenol) were significantly lower. In the pathway analysis performed using KEGG database, sphygolipid metabolism, sphygolipid signaling pathway, neuroactive ligand-receptor interaction and phenylalanine metabolism were found to be the most affected pathways. This study demonstrates distinct alterations in lipid and amino acid metabolism in PCOS and highlights the accumulation of exogenous molecules, including endocrine disruptors, in patient serum. By integrating metabolomic profiling with clinical phenotyping, our findings provide novel insights into PCOS pathophysiology and suggest potential serum biomarkers that may support early diagnosis and personalized therapeutic approaches.